Robotic Lateral Patient Transfer Device

HGH intends to enter into a contract with Able Innovations Inc. for the supply and support services of a robotic lateral patient transfer device. HGH intends to deploy an initial unit for clinical use and evaluation within the Hospital. The objective is to assess the solution's effectiveness in supporting safe patient handling, reducing caregiver strain, improving operational efficiency, and identifying opportunities for workflow optimization. The Supplier must be prepared to collaborate with HGH throughout the evaluation period which will include presence on-site to support implementation, collect performance feedback, and participate in product refinement activities where appropriate. This ACAN is not a competitive procurement process. Rather, it is a public notice intended to provide other suppliers with an opportunity to demonstrate, through a Statement of Capabilities, that they can meet all HGH's mandatory requirements. Suppliers who believe they can satisfy all mandatory requirements described in this ACAN must submit a detailed Statement of Capabilities by the Closing Date specified herein. Should no Supplier submit a Statement of Capabilities that demonstrates compliance with all mandatory requirements, HGH may proceed with the award of a contract to Able Innovations Inc.